Lite Strategy (LITS) Operating Leases (2020 - 2024)
Lite Strategy (LITS) posted quarterly Operating Leases of $10.6 million for Q1 2024, down 9.02% year-over-year from $11.7 million in Q2 2023, and down 3.61% quarter-over-quarter from $11.0 million in Q4 2023.
Lite Strategy (LITS) Operating Leases (2020 - 2024) Analysis & Trends
Lite Strategy's Operating Leases history runs 5 years deep, the most recent figure standing at $10.6 million for Q1 2024.
- In Q1 2024, Operating Leases fell 9.02% year-over-year to $10.6 million; the TTM figure through Mar 2024 stood at $10.6 million (down 9.02% YoY), while the FY2023 annual figure was $11.3 million, up 28.83% from the prior year.
- Operating Leases for Q1 2024 stood at $10.6 million, down from $11.0 million in the prior quarter.
- The five-year high for Operating Leases was $12.4 million in Q3 2022, with the low at $6.9 million in Q4 2021.
- The 5-year median for Operating Leases is $9.2 million (2022), against an average of $9.6 million.
- The sharpest annual moves came in 2021 and 2022: Operating Leases declined 17.97% in 2021, then soared 75.45% in 2022.
- Lite Strategy's Operating Leases stood at $7.8 million in 2020, then dropped by 12.59% to $6.9 million in 2021, then soared by 75.45% to $12.0 million in 2022, then slipped by 8.44% to $11.0 million in 2023, then retreated by 3.61% to $10.6 million in 2024.
- Business Quant data shows LITS's Operating Leases at $10.6 million in Q1 2024, $11.0 million in Q4 2023, and $11.3 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Lite Strategy | 36.96 Mn | 29.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 10.62 Mn |
| Dec 31, 2023 | 11.01 Mn |
| Sep 30, 2023 | 11.33 Mn |
| Jun 30, 2023 | 11.30 Mn |
| Mar 31, 2023 | 11.67 Mn |
| Dec 31, 2022 | 12.03 Mn |
| Sep 30, 2022 | 12.38 Mn |
| Jun 30, 2022 | 8.77 Mn |
| Mar 31, 2022 | 9.21 Mn |
| Dec 31, 2021 | 6.86 Mn |
| Sep 30, 2021 | 7.12 Mn |
| Jun 30, 2021 | 7.37 Mn |
| Mar 31, 2021 | 8.51 Mn |
| Dec 31, 2020 | 7.84 Mn |
| Sep 30, 2020 | 8.67 Mn |